Purdue Student Startups Awarded 50,000 Dollars to Disrupt Healthcare and Education Markets

Purdue Innovates Incubator awards 50,000 dollars to student startups echoSURE, VitaWave Tech, and CalcGPT during the 2026 New Venture Challenge.

By: AXL Media

Published: Apr 30, 2026, 9:56 AM EDT

Source: Information for this report was sourced from EurekAlert!

Fueling Collegiate Innovation Through Strategic Seed Funding

Four teams of aspiring student entrepreneurs at Purdue University have secured a collective 50,000 dollars in capital following the conclusion of the 2026 New Venture Challenge. This annual competition, organized by the Purdue Innovates Incubator, serves as a high stakes conclusion to a six workshop series designed to transition academic concepts into market ready enterprises. By providing early stage funding, the university seeks to empower students to tackle complex industrial problems while refining the financial models and go to market strategies necessary to attract professional investors.

Advancing Pediatric Safety via Novel Medical Diagnostics

The competition’s top honors and the Crowd Favorite award were claimed by echoSURE Inc., a medical device company that secured 22,500 dollars in prize money. The startup is focused on developing a verification tool for pediatric nasogastric feeding tube placement, a critical procedure where accuracy is paramount for patient safety. According to team member Raishma Anwar, the newly acquired funds will be instrumental in finalizing the company’s minimum viable product and securing essential intellectual property through utility and provisional patent filings.

Revolutionizing Hypertension Management with Wearable Tech

Securing second place and 15,000 dollars, VitaWave Tech Inc. is targeting the nearly 116 million American adults currently struggling with hypertension. The company is engineering a cuffless, in ear blood pressure monitoring system that provides continuous remote data without the discomfort of traditional intermittent cuffs. T. Hingba, a member of the VitaWave team, noted that this recognition bolsters the company’s credibility as they prepare for an FDA 510(k) Class II presubmission and work toward closing a 1.2 million dollar preseed funding round.